The goal of the meeting is to advance and promote research on infections associated with human cancer and other diseases, including in the setting of HIV-AIDS. The scientific topics will include the biology of oncogenic herpesviruses and associated human diseases, with specific emphasis on viral pathogenesis, viral latency and reactivation, viral gene expression and replication, host responses to infection, epidemiology, vaccine development, therapeutic intervention, clinical and translational research.

After holding the annual KSHV workshops for over a quarter century since the discovery of this cancer virus, substantial progress has been made on the biology of Kaposi’s sarcoma herpesvirus (KSHV), diseases associated with its infection, the treatment, and the disease pathogenesis. 

This 27th iteration of the International KSHV Conference series will continue to serve as the premier forum for the exchange of new developments in the field of KSHV, which is the etiological agent of the AIDS defining malignancy, Kaposi’s sarcoma (KS). Researchers in the KSHV field have held 26 previous annual conferences, typically attended by 100-184 participants, and 250-444 when held jointly with the EBV Association.